Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity
Status PubMed-not-MEDLINE Language English Country China Media print
Document type Journal Article
PubMed
25332991
PubMed Central
PMC4202474
DOI
10.3978/j.issn.2305-5839.2014.02.01
PII: atm-02-02-15
Knihovny.cz E-resources
- Keywords
- Glucan, children, lysozyme, mucosal immunity, saliva,
- Publication type
- Journal Article MeSH
BACKGROUND: The role of glucan in the stimulation of immune reactions is well established. In our report, we focused on the effects of orally administered glucan on nonspecific immunity of children with chronic respiratory problems. MATERIALS AND METHODS: We measured the levels of albumin, lysozyme. C-reactive protein (CRP) and calprotectin in the saliva of 60 children ages 8-12 years and evaluated the effects of 30-day treatment with 100 mg/d oral dose of glucan. RESULTS: We found a significant increase in the production of lysozyme, CRP and calprotectin in glucan-treated children. CONCLUSIONS: Short-term oral application of natural immunomodulator β-glucan significantly stimulated mucosal immunity of children with chronic respiratory problems.
See more in PubMed
Cobanoglu N, Galip N, Dalkan C, et al. Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma? Multidiscip Respir Med 2013;8:62. PubMed PMC
Francis JL, Gleeson M, Lugg DJ, et al. Trends in mucosal immunity in Antarctica during six Australian winter expeditions. Immunol Cell Biol 2002;80:382-90. PubMed
Soo-Quee Koh D, Choon-Huat Koh G.The use of salivary biomarkers in occupational and environmental medicine. Occup Environ Med 2007;64:202-10. PubMed PMC
Lee SY, Chang YS, Cho SH, et al. Allergic diseases and air pollution. Asia Pac Allergy 2013;3:145-54. PubMed PMC
Vetvička V, Richter J, Svozil V, et al. Placebo-driven clinical trials of Transfer Point Glucan #300 in children with chronic respiratory problems: III. Clinical findings. Am J Immunol 2013;9:88-93
Vetvička V, Richter J, Svozil V, et al. Placebo-driven clinical trials of Transfer Point Glucan #300 in children with chronic respiratory problems: antibody production. Am J Immunol 2013;9:43-7
Vetvicka V, Richter J, Svozil V, et al. Placebo-driven clinical trials of yeast-derived β-(1,3) glucan in children with chronic respiratory problems. Ann Transl Med 2013;1:26 PubMed PMC
Vetvicka V, Vetvickova J.A comparison of injected and orally administered β-glucans. JANA 2008;11:42-8
Vetvicka V, Vetvickova J.Effects of glucan on immunosuppressive actions of mercury. J Med Food 2009;12:1098-104. PubMed
Vetvicka V, Novak M. Biological action of b-glucan. In: Vetvicka V, Novak M. eds. Biology and Chemistry of Beta Glucan. Bentham Science Publishers, 2011:10-8.
Vetvicka V, Vetvickova J.Physiological effects of different types of beta-glucan. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:225-31. PubMed
Hamano K, Gohra H, Katoh T, et al. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int J Immunopharmacol 1999;21:531-40. PubMed
Bergendiova K, Tibenska E, Majtan J.Pleuran (β-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes. Eur J Appl Physiol 2011;111:2033-40. PubMed
Bonne NJ, Wong DT. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med 2012;4:82. PubMed PMC
Fábián TK, Hermann P, Beck A, et al. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci 2012;13:4295-320. PubMed PMC
Krasteva A, Kisselova A. Salivary acute phase proteins as biomarker in oral and systemic disease: acute phase proteins as early non-specific biomarkers of human and veterinary diseases. In: Veas F. eds. Tech, Rijeka, Croatia, 2011:69-88.
Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011;57:675-87. PubMed
Zhang L, Xiao H, Wong DT. Salivary biomarkers for clinical applications. Mol Diagn Ther 2009;13:245-59. PubMed
Bard E, Laibe S, Bettinger D, et al. New sensitive method for the measurement of lysozyme and lactoferrin for the assessment of innate mucosal immunity. part I: time-resolved immunofluorometric assay in serum and mucosal secretions. Clin Chem Lab Med 2003;41:127-33. PubMed
Gruys E, Toussaint MJ, Niewold TA, et al. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005;6:1045-56. PubMed PMC
Mohamed R, Campbell JL, Cooper-White J, et al. The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassays. Clin Transl Med 2012;1:19. PubMed PMC
Ramamoorthy RD, Nallasamy V, Reddy R, et al. A review of C-reactive protein: a diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci 2012;4:S422-6. PubMed PMC
Bosco Dhas DB, Bhat BV, Gane DB. Role of calprotectin in infection and inflammation. Curr Pediatr Res 2012;16:83-94
Cuida M, Brun JG, Tynning T, et al. Calprotectin levels in oral fluids: the importance of collection site. Eur J Oral Sci 1995;103:8-10. PubMed
Tieu DD, Peters AT, Carter RG, et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol 2010;125:667-75. PubMed PMC
Hsu K, Champaiboon C, Guenther BD, et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem 2009;8:290-305. PubMed PMC
Stríz I, Trebichavský I.Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004;53:245-53. PubMed
Johne B, Fagerhol MK, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-23. PubMed PMC
Kirstilä V, Tenovuo J, Ruuskanen O, et al. Salivary defense factors and oral health in patients with common variable immunodeficiency. J Clin Immunol 1994;14:229-36. PubMed
Lehtonen OP, Tenovuo J, Aaltonen AS, et al. Immunoglobulins and innate factors of immunity in saliva of children prone to respiratory infections. Acta Pathol Microbiol Immunol Scand C 1987;95:35-40. PubMed
Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005;7:119-33. PubMed PMC
Nieman DC, Henson DA, McMahon M, et al. Beta-glucan, immune function, and upper respiratory tract infections in athletes. Med Sci Sports Exerc 2008;40:1463-71. PubMed
Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials